Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study

Fig. 4

Kaplan-Meier survival analysis of 28-day survival after propensity score matching in the severe acute respiratory distress syndrome (ARDS) groups. The Kaplan-Meier survival curves censored at day 28 for severe ARDS group according to the presence of statin therapy. Treatment with statins significantly impacted 28-day survival among the patients with severe sepsis-associated ARDS (P = 0.0205, log-rank test)

Back to article page